Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: CME Group Inc., 3 years.
CME Group Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CME Group Inc. May 14, 202695.3%
-
CME Group Inc. May 8, 202595.3%
-
CME Group Inc. May 9, 202495.1%
-
CME Group Inc. May 4, 202394.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | CME Group Inc. | Grant or award | +645 | $225.00 | $145,125 |
| Feb 23, 2026 | CME Group Inc. | Open-market sale | −4,200 | $309.65 | $1,300,530 |
| Jun 25, 2025 | CME Group Inc. | Grant or award | +532 | $273.03 | $145,252 |
| Sep 3, 2024 | CME Group Inc. | Gift | −465 | — | — |
| Aug 30, 2024 | CME Group Inc. | Open-market sale | −7,593 | $214.59 | $1,629,382 |
| Jun 25, 2024 | CME Group Inc. | Grant or award | +748 | $194.10 | $145,187 |
| Dec 11, 2023 | CME Group Inc. | Open-market sale | −5,560 | $216.37 | $1,203,017 |
| Jun 26, 2023 | CME Group Inc. | Grant or award | +811 | $178.89 | $145,080 |
| Feb 16, 2023 | CME Group Inc. | Gift | −1,367 | — | — |
| Sep 30, 2021 | CME Group Inc. | Sold back to the company | −5,209 | $193.38 | $1,007,316 |
| Sep 16, 2020 | CME Group Inc. | Shares withheld for tax | −692 | $170.20 | $117,778 |
| Sep 15, 2020 | CME Group Inc. | Shares withheld for tax | −1,771 | $168.10 | $297,705 |
| Sep 14, 2020 | CME Group Inc. | Shares withheld for tax | −795 | $166.08 | $132,034 |
Questions about Bryan T. Durkin
What boards is Bryan T. Durkin on?
Bryan T. Durkin sits on the board of CME Group Inc.
How long has Bryan T. Durkin served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.